Orphan drug development remains a specialised segment with limited players
Recently, Syngene International was involved in the development of a drug for a rare disease that affects children. Dr Mahesh…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.